A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
141 locations incl. Birmingham
Sponsor: 89bio, Inc.
Sex: All·Age: 18 - 80
Code: NCT06318169·Phase 3·Recruiting